|1|Clinical and histopathological characteristics of familial prostate cancer in Finland. (21507186)
Pakkanen S.... Tammela T.L.
|2|Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. (20724726)
Bratt O.... Stattin P.
|3|Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features. (20184087)
|4|Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. (18830231)
FitzGerald L.M.... Dickinson J.L.
|5|Age at diagnosis and age at death in familial prostate cancer. (19939895)
Brandt A.... Hemminki K.
|6|Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. (18765558)
Cussenot O.... Cancel-Tassin G.
|7|Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. (18066601)
Johanneson B.... Thibodeau S.N.
|8|Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. (18767027)
Robbins C.M.... Kittles R.A.
|9|Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. (18368507)
Koike H.... Suzuki K.
|10|Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. (17683075)
Levin A.M.... Douglas J.A.
|11|Higher frequency of familial clustering of prostate cancer in French-Canadian men. (17698103)
Filion E.... Maugard C.M.
|12|Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. (17507624)
Cunningham J.M.... Thibodeau S.N.
|13|Identification of germline MLH1 alterations in familial prostate cancer. (16963262)
Fredriksson H.... Schleutker J.
|14|Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population. (16859836)
Okugi H.... Suzuki K.
|15|Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. (16702373)
Hebbring S.J.... Thibodeau S.N.
|16|Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. (16515992)
Roemeling S.... SchrAPder F.H.
|17|Chromogranin A expression in familial versus sporadic prostate cancer. (16286114)
Sciarra A.... Di Silverio F.
|18|Role of a CYP17 promoter polymorphism for familial prostate cancer risk in Germany. (15865082)
Vesovic Z.... Maier C.
|19|Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. (15534086)
Wiklund F.... GrAPnberg H.
|20|Genomewide linkage analysis of familial prostate cancer in the Japanese population. (14666403)
Matsui H.... Inoue I.
|21|Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. (15527908)
Debes J.D.... Thibodeau S.N.
|22|-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. (14961571)
Jonsson B.A.... GrAPnberg H.
|23|Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. (12926131)
Nakazato H.... Yamanaka H.
|24|A systematic review and meta-analysis of familial prostate cancer risk. (12780833)
Johns L.E.... Houlston R.S.
|25|Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer. (12746844)
Elkins D.A.... Liu W.
|26|Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study. (12767526)
Suzuki K.... Yamanaka H.
|27|Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer. (15040862)
Downing S.R.... Kantoff P.W.
|28|Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy. (12767361)
Paiss T.... Gschwend J.E.
|29|Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study. (14601030)
Cunningham J.M.... Thibodeau S.N.
|30|Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage. (14981950)
Koike H.... Yamanaka H.
Stanford J.L.... Ostrander E.A.
|32|Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer. (11751379)
Wu Y.Q.... Cooney K.A.
|33|A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. (11295622)
|34|Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. (11254448)
Xu J.... Isaacs W.B.
|35|Genetic changes in familial prostate cancer by comparative genomic hybridization. (11170152)
RAPkman A.... Schleutker J.
|36|BRCA1 and BRCA2 have a limited role in familial prostate cancer. (10728701)
Sinclair C.S.... Couch F.J.
|37|Familial prostate cancer from the family-cancer database. (10741282)
Hemminki K.... Dong C.
|38|Significance of measurement of prostate specific antigen (PSA) in familial prostate cancer lines. (9607395)
Ohtake N.... Tari K.
|39|Familial prostate cancer in Japan. (9559839)
Ohtake N.... Tsuji T.
|40|Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators. (9724085)
Edwards S.M.... Eeles R.A.
|41|Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. (9497242)
Eeles R.A.... Foulkes W.D.
|42|Familial prostate cancer in four brothers. (9712452)
Ohtake N.... Tsuji T.
|43|Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. (9836474)
Dunsmuir W.D.... Eeles R.A.
|44|Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. (9088267)
Eeles R.A.... Dowe A.
|45|Familial prostate cancer studies in Utah. (9088268)
Neuhausen S.L.... Cannon-Albright L.
|46|Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. (9311739)
McIndoe R.A.... Ostrander E.A.
|47|Familial prostate cancer: a different disease? (9366343)
Kupelian P.A.... Suh J.H.
|48|Familial prostate cancer in Sweden. A nationwide register cohort study. (8630920)
GrAPnberg H.... Damber J.E.
|49|Familial breast cancer risks. Effects of prostate and other cancers. (8508396)
Anderson D.E.... Badzioch M.D.
|50|Mendelian inheritance of familial prostate cancer. (1565627)
Carter B.S.... Walsh P.C.